Intervention Review

You have free access to this content

Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis

  1. Abigail Fraser2,
  2. Mical Paul3,
  3. Ahmed Attamna4,
  4. Leonard Leibovici1,*

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 4 MAR 2009

DOI: 10.1002/14651858.CD005435.pub2

Database Title

Additional Information

How to Cite

Fraser A, Paul M, Attamna A, Leibovici L. Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD005435. DOI: 10.1002/14651858.CD005435.pub2.

Author Information

  1. 1

    Beilinson Campus, Rabin Medical Center, Department of Medicine E, Petah-Tiqva, Israel

  2. 2

    University of Bristol, Oakfield House, Department of Social Medicine, MRC Centre for Causal Analysis in Translational Epidemiology, Bristol, UK

  3. 3

    Rabin Medical Center, Infectious Diseases Unit and Department of Medicine E, Petah-Tikva, Israel

  4. 4

    Regional Tuberculosis Clinic, Hadera, Israel

*Leonard Leibovici, Department of Medicine E, Beilinson Campus, Rabin Medical Center, 39 Jabotinsky Street, Petah-Tiqva, 49100, Israel. leibovic@post.tau.ac.il. leibovici@clalit.org.il.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 8 JUL 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (58K)Standard (132K)Full (141K)

References

Additional references

  1. Additional references
  2. References to other published versions of this review
ATS 2000
  • American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Journal of Respiratory and Critical Care Medicine 2000;161 (4 Pt 2):221-47.
CDC 2003
  • Centers for Disease Control and Prevention (CDC), American Thoracic Society. Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003. MMWR 2003;52(31):735-9.
Dye 1999
  • Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC, for the WHO Global Surveillance and Monitoring Project. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. JAMA 1999;282(7):677-86.
Fraser 2006
  • Fraser A, Paul M, Attamna A, Leibovici L. Chemoprophylaxis to prevent tuberculosis in persons at risk for multidrug-resistant tuberculosis: systematic review. International Journal of Tuberculosis and Lung Disease 2006;1(1):19-23.
Higgins 2005
  • Higgins J, Green S, editors. Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Handbook for Systematic Reviews of Interventions [updated March 2005]; Appendix 5b. www.cochrane.org/resources/handbook/hbook.htm (accessed 18 April 2005).
Ijaz 2006
  • Ijaz K, Jereb JA, Lambert LA, Bower WA, Spradling PR, McElroy PD, et al. Severe or fatal liver injury in 50 patients in the United States taking rifampbin and pyrazinamide for latent tuberculosis infection. Clinical Infectious Diseases 2006;42(3):346-55.
Jasmer 2002
Kritski 1996
  • Kritski AL, Marques MJ, Rabahi MF, Silva Vieira MAM, Werneck-Barroso E, Carvalso CES, et al. Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis. American Journal of Respiratory and Critical Care Medicine 1996;153(1):331-5.
Mandell 2000
  • Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th Edition. Philadelphia: Churchill Livingstone, 2000.
Pablos-Mendez 2002
  • Pablos-Mendez A, Gowda DK, Frieden TR. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework. Bulletin of the World Health Organization 2002;80(6):489-500.
Papastavros 2002
  • Papastavros T, Dolovich LR, Holbrook A, Whitehead L, Loeb M. Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis. Canadian Medical Association Journal 2002;167(2):131-6.
Passannante 1994
Schaaf 1999
  • Schaaf HS, Vermeulen HA, Gie RP, Beyers N, Donald PR. Evaluation of young children in household contact with adult multidrug-resistant pulmonary tuberculosis cases. Pediatric Infectious Disease Journal 1999;8(6):494-500.
Schaaf 2002
  • Schaaf HS, Gie RP, Kennedy M, Beyers N, Hesseling PB, Donald PR. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up. Pediatrics 2002;109(5):765-71.
Smieja 2000
  • Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: ]
WHO 2004
  • World Health Organization, Stop TB Dept. Anti-tuberculosis drug resistance in the world : third global report / the WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 1999-2002. Geneva: World Health Organization, 2004.
WMA
  • The World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. www.wma.net/e/policy/b3.htm (accessed 15 May 2005).
Woldehanna 2004
  • Woldehanna S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: ]
Yee 2003
  • Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. American Journal of Respiratory and Critical Care Medicine 2003;167(11):1472-7.

References to other published versions of this review

  1. Additional references
  2. References to other published versions of this review
Fraser 2005
  • Fraser A, Paul M, Attamna A, Leibovici L. Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: ]
View Full Article (HTML) Summary (58K)Standard (132K)Full (141K)